Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: acne.
- Who it may be relevant to
- Registry conditions: Acne. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital: the COPACNE Cohort.
Overview
With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life. This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).
Detailed description
All patients going for the first time in specialized consultation "acne" at Nantes University Hospital , and who meet the inclusion criteria will be included in the COPACNE cohort. Inclusion will take place at the first consultation, after information and agreement of the patient and, if applicable, his or her legal representatives. The frequency of each patient's follow-up visits will be determined on a case-by-case basis according to the patient's medical needs (generally, the interval between 2 visits is between 1 and 4 months).
Interventions
- Other acne
Patient with acne
Primary outcome measures
- Measure of Acne stage [Time frame: 2 years]
Secondary outcome measures (3)
- assessing patients' quality of life [Time frame: 2 years]
- cost of acne illness [Time frame: 2 years]
- Bacteriological sample to find Propionibacterium acnes, Hormonal check-up on blood sample [Time frame: 2 years]
Eligibility criteria
Inclusion criteria
- Patient with acne
- Patient (or parents/guardians for minors) who are not opposed to participating in the cohort.
- Subjects affiliated to an appropriate health insurance
Exclusion criteria
- Dermatosis of the face other than acne
- Refusal to participate by the minor or parent/guardian
- Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- CHU de Nantes — Nantes
Identifiers
NCT: NCT03465150 · RC17_0218